Potential IPF Treatment, Found Using AI, May Move Into Trial, Insilico Says

Potential  IPF Treatment, Found Using AI, May Move Into Trial, Insilico Says

288442

Potential IPF Treatment, Found Using AI, May Move Into Trial, Insilico Says

Insilico Medicine announced that it has found a new therapeutic target and potential therapy candidate for idiopathic pulmonary fibrosis (IPF) using artificial intelligence (AI), a company specialty. The potential therapy, a small molecule inhibitor, has been validated in preclinical tests in human tissue and animal models of IPF. Work here showed both efficacy and safety, potentially supporting a request to test the molecule in a clinical trial, Insilico said in a press release. “To my knowledge…

You must be logged in to read/download the full post.